AAAAAA

   
Results: 1-8 |
Results: 8
RESPIRATORY ILLNESS, BETA-AGONISTS, AND RISK OF IDIOPATHIC DILATED CARDIOMYOPATHY - THE WASHINGTON, DC, DILATED CARDIOMYOPATHY STUDY - REPLY
Authors: COUGHLIN SS METAYER C MATHER FJ MCCARTHY EP WALDHORN RE GERSH BJ BAUGHMAN KL
Citation: Ss. Coughlin et al., RESPIRATORY ILLNESS, BETA-AGONISTS, AND RISK OF IDIOPATHIC DILATED CARDIOMYOPATHY - THE WASHINGTON, DC, DILATED CARDIOMYOPATHY STUDY - REPLY, American journal of epidemiology, 144(5), 1996, pp. 528-529
INDICATIONS AND STANDARDS FOR USE OF NASAL CONTINUOUS POSITIVE AIRWAYPRESSURE (CPAP) IN SLEEP-APNEA SYNDROMES (VOL 150, PG 1738, 1994)
Authors: SMITH PL HUDGEL DW OLSON LG PARTINEN M RAPOPORT DM ROSEN CL SKATRUD JB WALDHORN RE WESTBROOK PR YOUNG T
Citation: Pl. Smith et al., INDICATIONS AND STANDARDS FOR USE OF NASAL CONTINUOUS POSITIVE AIRWAYPRESSURE (CPAP) IN SLEEP-APNEA SYNDROMES (VOL 150, PG 1738, 1994), American journal of respiratory and critical care medicine, 151(2), 1995, pp. 578-578
FLUMAZENIL EFFECTS ON BREATHING AND ENDOZEPINE LEVELS IN PATIENTS WITH SLEEP-APNEA
Authors: BALIAN JD WALDHORN RE IMPAGNATIELLO F GUIDOTTI A WOOSLEY RL FLOCKHART DA
Citation: Jd. Balian et al., FLUMAZENIL EFFECTS ON BREATHING AND ENDOZEPINE LEVELS IN PATIENTS WITH SLEEP-APNEA, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 145-145
RESPIRATORY ILLNESS, BETA-AGONISTS, AND RISK OF IDIOPATHIC DILATED CARDIOMYOPATHY - THE WASHINGTON, DC, DILATED CARDIOMYOPATHY STUDY
Authors: COUGHLIN SS METAYER C MCCARTHY EP MATHER FJ WALDHORN RE GERSH BJ DUPRAW S BAUGHMAN KL
Citation: Ss. Coughlin et al., RESPIRATORY ILLNESS, BETA-AGONISTS, AND RISK OF IDIOPATHIC DILATED CARDIOMYOPATHY - THE WASHINGTON, DC, DILATED CARDIOMYOPATHY STUDY, American journal of epidemiology, 142(4), 1995, pp. 395-403
ANALGESIA, SEDATION AND PARALYSIS IN THE INTENSIVE-CARE UNIT
Authors: BERGER I WALDHORN RE
Citation: I. Berger et Re. Waldhorn, ANALGESIA, SEDATION AND PARALYSIS IN THE INTENSIVE-CARE UNIT, American family physician, 51(1), 1995, pp. 166-172
INDICATIONS AND STANDARDS FOR USE OF NASAL CONTINUOUS POSITIVE AIRWAYPRESSURE (CPAP) IN SLEEP-APNEA SYNDROMES
Authors: SMITH PL HUDGEL DW OLSON LG PARTINEN M RAPOPORT DM ROSEN CL SKATRUD JB WALDHORN RE WESTBROOK PR YOUNG T
Citation: Pl. Smith et al., INDICATIONS AND STANDARDS FOR USE OF NASAL CONTINUOUS POSITIVE AIRWAYPRESSURE (CPAP) IN SLEEP-APNEA SYNDROMES, American journal of respiratory and critical care medicine, 150(6), 1994, pp. 1738-1745
ATTENDED HOME TITRATION OF NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY FOR OBSTRUCTIVE SLEEP-APNEA
Authors: WALDHORN RE WOOD K
Citation: Re. Waldhorn et K. Wood, ATTENDED HOME TITRATION OF NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY FOR OBSTRUCTIVE SLEEP-APNEA, Chest, 104(6), 1993, pp. 1707-1710
DIFFERENTIAL LOBE LAVAGE FOR DIAGNOSIS OF ACUTE PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS RECEIVING PROPHYLACTIC AEROSOLIZED PENTAMIDINE THERAPY
Authors: READ CA CERRONE F BUSSENIERS AE WALDHORN RE LAVELLE JP PIERCE PF
Citation: Ca. Read et al., DIFFERENTIAL LOBE LAVAGE FOR DIAGNOSIS OF ACUTE PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS RECEIVING PROPHYLACTIC AEROSOLIZED PENTAMIDINE THERAPY, Chest, 103(5), 1993, pp. 1520-1523
Risultati: 1-8 |